Dr. Eric C. Feliberti, MD

Dr. Feliberti practices at Sentara Norfolk General Hospital in Norfolk, Virginia, part of Sentara Health.

Dr. Feliberti's NPI, 1528073343, was assigned on July 30, 2006. Dr. Feliberti graduated from University of Texas Medical Branch at Galveston in 1999. Dr. Feliberti holds Virginia license 0101240094.

Dr. Feliberti's primary practice is Sentara Norfolk General Hospital, at 600 Gresham Dr, Norfolk, VA 23507 in Norfolk City. The practice phone is (757) 388-3000.

Dr. Feliberti's primary practice is Sentara Norfolk General Hospital in Norfolk, Virginia, part of Sentara Health. Dr. Feliberti is also affiliated with Sentara Leigh Hospital. The medical group on file is EVMS Medical Group. Dmand AI also links Dr. Feliberti to 3 more hospitals, 1 group practice or clinic and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Feliberti practices, 7 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Feliberti's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Feliberti is licensed in Virginia.

CMS data shows 244 Medicare services from Dr. Feliberti across 4 procedure codes in 2024, for 208 Medicare patients. Medicare paid $23,041 for them.

CMS counts 208 Medicare patients who saw Dr. Feliberti in 2024. The largest group is 65 to 74, with 97 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Feliberti's median patient age at 65, with 66% women.

In 2024, Dr. Feliberti wrote 40 Medicare Part D claims for 25 patients. 100% of them were for generic drugs. CMS names the drug for 19 of them, across 1 drug with 11 or more claims each, at $101 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

Dr. Feliberti accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 27 procedures of melanoma (skin cancer) excision by Dr. Feliberti, more than 79% of the clinicians it reports for that procedure.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Mastectomy: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Dr. Feliberti, published from 2011 to 2024. The most frequent topics are Breast Neoplasms, Lymph Nodes and Sentinel Lymph Node Biopsy. Dr. Feliberti's most frequent co-authors are Roger Ronald Perry, MD, Marybeth Scavone Hughes, MD and Gretchen M. Ahrendt, MD.

Dmand AI links Dr. Feliberti to 4 clinical trials, 2 of them phase 3 studies. 2 are still active or recruiting. Conditions studied include Rectal Neoplasms, Rectal Diseases and Breast Neoplasms. Alliance for Clinical Trials in Oncology sponsors the most, 3.

CMS Open Payments shows 62 general payments to Dr. Feliberti from 14 drug and device companies from 2016 to 2025. Education make up the largest share, 75% of the total. Intuitive Surgical, Inc. paid the most, $12,711.

Dr. Feliberti graduated from University of Texas Medical Branch at Galveston in 1999.